1. From the Epidemiology and Prevention Division (A.H.), Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan; Department of Clinical Pharmacology and Therapeutics (A.H., H.M., T.Ha., M.S., T.Ob., Y.I.), Planning for Drug Development and Clinical Evaluation (K.T., T.Oh., M.K., K.A., T.Hi., Y.I.), Physical Medicine and Rehabilitation (T.K., S.-I.I.), and Environmental Health Sciences (H.S.), Tohoku University Graduate School of Pharmaceutical Sciences and Medicine,...